TY  - JOUR
AU  - Carmona-Bayonas, A
AU  - Jimenez-Fonseca, P
AU  - de Castro, E M
AU  - Mata, E
AU  - Biosca, M
AU  - Custodio, A
AU  - Espinosa, J
AU  - Vázquez, E G
AU  - Henao, F
AU  - Ayala de la Peña, F
PY  - 2018
DO  - 10.1007/s12094-018-1983-4
UR  - http://hdl.handle.net/10668/13225
T2  - Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
AB  - Febrile neutropenia (FN) is a common dose-limiting toxicity of chemotherapy, with a profound impact on the evolution of patients with cancer, due to the potential development of serious complications, mortality, delays, and decrease in treatment...
LA  - en
KW  - CISNE score
KW  - Clinical practice guideline
KW  - Febrile neutropenia
KW  - SEOM
KW  - Adult
KW  - Antineoplastic Agents
KW  - Clinical Trials as Topic
KW  - Disease Management
KW  - Febrile Neutropenia
KW  - Granulocyte Colony-Stimulating Factor
KW  - Humans
KW  - Neoplasms
KW  - Practice Guidelines as Topic
KW  - Prognosis
KW  - Risk Assessment
KW  - Severity of Illness Index
KW  - Societies, Medical
TI  - SEOM clinical practice guideline: management and prevention of febrile neutropenia in adults with solid tumors (2018).
TY  - research article
VL  - 21
ER  -